Intellicheck Mobilisa, Inc. v. Wizz Systems, LLC

173 F. Supp. 3d 1085, 2016 U.S. Dist. LEXIS 40524
CourtDistrict Court, W.D. Washington
DecidedMarch 28, 2016
DocketCASE NO. C15-0366JLR
StatusPublished
Cited by6 cases

This text of 173 F. Supp. 3d 1085 (Intellicheck Mobilisa, Inc. v. Wizz Systems, LLC) is published on Counsel Stack Legal Research, covering District Court, W.D. Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Intellicheck Mobilisa, Inc. v. Wizz Systems, LLC, 173 F. Supp. 3d 1085, 2016 U.S. Dist. LEXIS 40524 (W.D. Wash. 2016).

Opinion

CLAIM CONSTRUCTION ORDER

JAMES L. ROBART, United States District Judge

I.INTRODUCTION

This matter comes before the court on the parties’ dispute regarding the construction of certain patent claim terms. The court has reviewed the parties’ claim construction briefs (Pltf. Op. Br. (Dkt. # 38); Def. Op. Br. (Dkt. # 39); Pltf. Resp. (Dkt. # 41); Def. Resp. (Dkt. # 42)), all materials filed in support thereof, the balance of the record, and the relevant law, and has heard oral argument at a February 4, 2016, claim construction hearing (Dkt. # 49). (See also Pltf. Letter. Br. (Dkt. # 55); Def. Letter Br. (Dkt. # 59).) Being fully advised, the court construes the disputed terms as set forth below.

II. BACKGROUND

This is a patent infringement case involving apparatuses, systems, and methods for verifying the authenticity of identification documents such as driver licenses (“the Invention”), (See 2d Am. Compl. (Dkt. # 45) ¶¶ 1, 3; Pltf. Op. Br. at 5; Def. Op. Br. at 7.) Plaintiff Intellicheck Mobili-sa, Inc. (“Intellicheck”) is the owner by assignment of five patents — four of which are continuation patents — describing the Invention: United States Patent No. 5,864,-623 (“the ’623 Patent”), United States Patent No. 6,463,416 (“the ’416 Patent”), United States Patent No.‘6,920,437 (“the ’437 Patent”), United States Patent No. 7,478,-067 (“the ’067 Patent”), and United States Patent No. 7,899,751 (“the ’751 Patent”) (collectively, “the Patents-in-Suit”).1 (2d Am. Compl. ¶¶ 11, 24, 37, 50, 63; Def. Op. Br. at 7 n.l.) Intellicheck asserts that Defendant Wizz Systems, LLC, d/b/a ID-Scan.net (“IDScan”), has infringed its patent rights both directly and indirectly. (See 2d Am. CompL)

The parties dispute the meaning of the following nine claim terms in the Patents-in-Suit:

1. human recognizable;
2. jurisdiction key;
3. Issuer Identification Number;
4. a checksum corresponding to selected human recognizable ones of said jurisdiction segments AND2 a correspond[1089]*1089ing reference checksum from said machine coded information;
5. means for reading the information of said document into said programmable apparatus;
6. means for determining whether said document includes a license format corresponding to a reference license format;
7. A programmable apparatus for authenticating a document AND authenticating, authentication, authenti- , cate; ' • -
8. first circuitry at said'first location for receiving the information read from the driver license and determining whether the read information read [sic]3 comports with said predetermined format; -
9. a jurisdiction discriminator engine ' ' adapted to determine and authenticate a jurisdiction.

(Joint Statement (Dkt. # 37) at 3-12.) The parties’ disputed terms áre now before the court.

III. DISCUSSION

A. Law of Claim Construction

1. Generally

The court has the sole responsibility for construing patent claims. Markman v. Westview Instruments, Inc., 517 U.S. 370, 372, 116 S.Ct. 1384, 134 L.Ed.2d 577 (1996). Subsequent authority has clarified that the court construes claims as a matter of law, though the court may make subsidiary factual findings regarding extrinsic evidence. Teva Pharm. USA, Inc. v. Sandez, Inc., — U.S. -, 135 S.Ct. 831, 836-38, 840-42, — L.Ed.2d-(2015).4 In practice, executing the Markman mandate means following rules that rank the importance of various sources of evidence of the “true” meaning of claim terms.

The' Federal Circuit reiterated its view of the claim construction rules in Phillips v. AWH Corp., 415 F.3d 1303 (Fed.Cir.2005) (en banc). Although the case focused on the role of dictionaries in claim construction, it also reviewed the claim construction process. Intrinsic evidence, which includes the patent and its prosecution history, is the primary source from which to derive a claim’s meaning. Id. at 1314. The court’s task is to determine the “ordinary and customary meaning” of the terms of a Claim in the eyes of a person of ordinary skill in the art on the filing date of the patent. Id. at 1313 (quoting Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed.Cir.1996)). In its review of intrinsic evidence, the court should begin with the language of both the asserted claim and other claims' in the patent. Id. at 1314; see also Innova/Pure Water, Inc. v. Safari Water Filtration Sys., Inc., 381 F.3d 1111, 1116 (Fed.Cir.2004) (“[C]laim [1090]*1090construction analysis must begin and remain centered on the claim language itself”).

The court must read claim language, however, in light of the remainder of the patent’s specification. Phillips, 415 F.3d at 1316 (“[T]he specification necessarily informs the proper construction of the claims.”). The specification acts as a “concordance” for claim terms, and is thus the best source beyond claim language for understanding claim terms. Id. at 1315. The inventor is free to use the specification to define claim terms as she wishes, and the court must defer to the inventor’s definitions. Id. at 1316 (“[T]he inventor’s lexicography governs.”). The court should “rely heavily” on the specification in interpreting claim terms. Id. at 1317. The court should not, however, commit the “cardinal sin” of claim construction — impermissibly reading limitations from the specification into the claims. Id. at 1320 (citing SciMed Life Sys. v. Advanced Cardiovascular Sys., Inc., 242 F.3d 1337, 1340 (Fed.Cir.2001)). Although a court should limit the meaning of a claim where the “specification makes clear at various points that the claimed invention is naiTower than the claim language might imply,” the court must not read particular embodiments and examples appearing in the specification into the claims unless the specification requires it. Alloc, Inc. v. Int'l Trade Comm’n, 342 F.3d 1361, 1370 (Fed.Cir.2003); Constant v. Advanced Micro-Devices, Inc., 848 F.2d 1560, 1571 (Fed.Cir.1988). Additionally, while drawings illustrating the invention may be used in construing claims, “the mere fact that the patent drawings depict a particular embodiment of the patent does not operate to limit the claims to that specific configuration.” Prima Tek II, L.L.C. v. Polypap, S.A.R.L., 318 F.3d 1143, 1148 (Fed.Cir.2003).

More recently, the Federal Circuit has continued to stress its emphasis on the importance of reading the claims in the context of the specification and prosecution history. Laryngeal Mask Co. Ltd. v. Ambu, 618 F.3d 1367

Free access — add to your briefcase to read the full text and ask questions with AI

Related

People v. Quintana CA4/2
California Court of Appeal, 2025
People v. Garcia CA4/2
California Court of Appeal, 2025
People v. Cline CA4/2
California Court of Appeal, 2025
People v. Bowman CA4/2
California Court of Appeal, 2025
People v. Jimenez CA4/2
California Court of Appeal, 2025

Cite This Page — Counsel Stack

Bluebook (online)
173 F. Supp. 3d 1085, 2016 U.S. Dist. LEXIS 40524, Counsel Stack Legal Research, https://law.counselstack.com/opinion/intellicheck-mobilisa-inc-v-wizz-systems-llc-wawd-2016.